Michael Schaeffer
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Dr. Michael Schaeffer is an Executive Director & Chief Business Officer at Vivoryon Therapeutics NV.
He is on the Board of Directors at Vivoryon Therapeutics NV.
Dr. Schaeffer was previously employed as a Chief Executive Officer & Managing Director by Crelux GmbH and a Chief Executive Officer & Managing Director by SiREEN AG.
He received his doctorate degree from Ludwig-Maximilians-Universität München.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
Crelux GmbH
Crelux GmbH BiotechnologyHealth Technology Provides drug discovery services | Directeur Général | 01/03/2016 |
SiREEN AG
SiREEN AG Miscellaneous Commercial ServicesCommercial Services Researches and discovers drugs specializing in diseases such as colon cancer and immune tolerance | Directeur Général | 01/01/2004 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
SiREEN AG
SiREEN AG Miscellaneous Commercial ServicesCommercial Services Researches and discovers drugs specializing in diseases such as colon cancer and immune tolerance | Commercial Services |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivoryon Therapeutics NV
Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
Crelux GmbH
Crelux GmbH BiotechnologyHealth Technology Provides drug discovery services | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national